We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

2 hedge funds and large institutions have $1.98M invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 216 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% less call options, than puts

Call options by funds: $13.6M | Put options by funds: $51.5M

99% less funds holding

Funds holding: 219 → 2 (-217)

100% less capital invested

Capital invested by funds: $4.35B → $1.98M (-$4.35B)

100% less funds holding in top 10

Funds holding in top 10: 13 → 0 (-13)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 216

Holders
2
Holders Change
-217
Holders Change %
-99.09%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
216
Calls
$13.6M
Puts
$51.5M
Net Calls
-$37.9M
Net Calls Change
-$118M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$351M
2
BlackRock
BlackRock
New York
-$300M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$292M
4
BC
Boxer Capital
California
-$204M
5
7IH
72 Investment Holdings
Connecticut
-$198M
Name Holding Trade Value Shares
Change 		Change in
Stake
CP
126
CenterBook Partners
Connecticut
– -$1.47M -13,702 Closed
Dimensional Fund Advisors
127
Dimensional Fund Advisors
Texas
– -$1.39M -12,946 Closed
JFG
128
Jefferies Financial Group
New York
– -$1.35M -12,565 Closed
Royal Bank of Canada
129
Royal Bank of Canada
Ontario, Canada
– -$1.34M -12,454 Closed
MAP
130
Moody Aldrich Partners
Massachusetts
– -$1.31M -12,243 Closed
Allianz Asset Management
131
Allianz Asset Management
Germany
– -$1.31M -12,200 Closed
RC
132
Renaissance Capital
Connecticut
– -$1.23M -11,503 Closed
PA
133
Profund Advisors
Maryland
– -$1.23M -11,488 Closed
Janus Henderson Group
134
Janus Henderson Group
United Kingdom
– -$1.09M -10,203 Closed
State Board of Administration of Florida Retirement System
135
State Board of Administration of Florida Retirement System
Florida
– -$1.09M -10,174 Closed
IC
136
IEQ Capital
California
– -$1.07M -10,000 Closed
AR
137
Advisory Research
Illinois
– -$1.01M -9,455 Closed
KCM
138
Kennedy Capital Management
Missouri
– -$1M -9,348 Closed
Envestnet Asset Management
139
Envestnet Asset Management
Illinois
– -$997K -9,294 Closed
Skandinaviska Enskilda Banken (SEB)
140
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$970K -9,041 Closed
EAM
141
Erste Asset Management
Austria
– -$947K -8,800 Closed
Neuberger Berman Group
142
Neuberger Berman Group
New York
– -$883K -8,228 Closed
LCM
143
Legato Capital Management
California
– -$867K -8,074 Closed
AQR Capital Management
144
AQR Capital Management
Connecticut
– -$855K -7,965 Closed
ProShare Advisors
145
ProShare Advisors
Maryland
– -$793K -7,391 Closed
UBS Group
146
UBS Group
Switzerland
– -$777K -7,244 Closed
AG
147
Algert Global
California
– -$775K -7,220 Closed
PCM
148
Prelude Capital Management
New York
– -$773K -7,200 Closed
Teacher Retirement System of Texas
149
Teacher Retirement System of Texas
Texas
– -$769K -7,161 Closed
ASRS
150
Arizona State Retirement System
Arizona
– -$723K -6,735 Closed
4 5
6
7 8

RXDX Hedge Fund Activity: Q2 2023 in Review

2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Prometheus Biosciences, Inc. Common Stock (RXDX) for Q2 2023, worth a combined $1.98M — down 100% from $4.35B a quarter earlier.

Sellers outnumbered buyers: 216 funds closed out of RXDX and 0 opened new positions — a net loss of 216 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $351M sold.

  • 2 institutional investors held Prometheus Biosciences, Inc. Common Stock (RXDX) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $1.98M of Prometheus Biosciences, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Prometheus Biosciences, Inc. Common Stock positions in Q2 2023 and 216 closed out, a net change of -216 holders.
  • The largest Prometheus Biosciences, Inc. Common Stock seller in Q2 2023 was RTW Investments, an estimated $351M sold.

Based on aggregated 13F filings for Q2 2023.